Jove
Visualize
联系我们

相关概念视频

Amyloid Fibrils03:03

Amyloid Fibrils

6.9K
6.9K
Amyloid Fibrils03:03

Amyloid Fibrils

12.9K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.9K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

967
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
967
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

798
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
798

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy.

Circulation. Heart failure·2026
Same author

Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis.

JACC. CardioOncology·2026
Same author

Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: Findings from ATTRibute-CM.

European journal of heart failure·2026
Same author

Baseline characteristics of patients with transthyretin amyloidosis with cardiomyopathy in the CARDIO-TTRansform trial of eplontersen.

European journal of heart failure·2026
Same author

Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR Amyloidosis.

Clinical pharmacokinetics·2026
Same journal

Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

Lancet (London, England)·2026
Same journal

Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

Lancet (London, England)·2026
Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026
Same journal

Documenting hospice care.

Lancet (London, England)·2026
Same journal

After the wood chipper.

Lancet (London, England)·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Mar 28, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

8.2K

系统性粉症

Ashutosh D Wechalekar1, Julian D Gillmore1, Philip N Hawkins1

  • 1National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.

Lancet (London, England)
|January 1, 2016
PubMed
概括
此摘要是机器生成的。

由蛋白纤维沉积引起的全身性粉症的诊断越来越多. 诊断和新疗法的进步提供了希望, 但早期发现对于这些罕见疾病的改善至关重要.

更多相关视频

Performing and Processing FNA of Anterior Fat Pad for Amyloid
09:41

Performing and Processing FNA of Anterior Fat Pad for Amyloid

Published on: October 30, 2010

56.5K
Rapid Generation of Amyloid from Native Proteins In vitro
05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

6.6K

相关实验视频

Last Updated: Mar 28, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

8.2K
Performing and Processing FNA of Anterior Fat Pad for Amyloid
09:41

Performing and Processing FNA of Anterior Fat Pad for Amyloid

Published on: October 30, 2010

56.5K
Rapid Generation of Amyloid from Native Proteins In vitro
05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

6.6K

科学领域:

  • 罕见疾病
  • 蛋白质错误折叠的疾病
  • 系统性粉症

背景情况:

  • 系统性粉症是由蛋白纤维在组织中的沉积引起的.
  • 系统性轻链氨基粉症 (AL) 是最常见的,野生型心脏氨基粉症 (ATTRwt) 增加.
  • 这些罕见疾病的流行病学,诊断和治疗正在发展.

研究的目的:

  • 审查系统性粉症的当前流行病学.
  • 讨论诊断方法的进展.
  • 突出治疗策略的进展.

主要方法:

  • 使用激光捕获和质谱学改进了粉样纤维的类型.
  • 使用心脏MRI和骨光学标记器进行心脏粉症评估.
  • 对新型化疗剂和新兴治疗点的审查.

主要成果:

  • 新的化疗改善了AL粉症的存活率.
  • 通过先进的成像, 心脏粉症的诊断更准确.
  • 尽管治疗进展,但早期诊断仍然是一个重大挑战.

结论:

  • 新的诊断工具可以更好地检测和类型化粉症.
  • 像RNA抑制剂和免疫疗法这样的新兴疗法显示出有前途.
  • 转变结果需要解决晚期疾病和早期诊断的挑战.